WHO works towards universal access to health products by fostering innovation based on public health needs and reinforcing health products selection, use and supply systems. It promotes equitable access by stimulating research and development for health products to treat diseases that predominantly affect the poor and seeking innovative financing systems to fund the research.
WHO provides global leadership to shape the future of health products based on public health needs. WHO is defining a research agenda to respond to future health emergencies and promote innovation for health products to treat diseases that predominantly affect the poor.
WHO supports countries to formulate evidence-based policies and ensure good practice and good governance throughout the supply chain from selecting the right products to using them correctly. It also develops tools to assess situations, monitor and measure progress on access to quality health products.
Events
All →Twenty-fifth Expert Committee on Selection and Use of Essential Medicines
WHO, WIPO, WTO to host symposium on boosting manufacturing for non-communicable diseases
Registration open for the 5th WHO-WIPO-WTO Trilateral Cooperation Technical Webinar
Publications
All →
Briefing note on access-oriented technology licensing
As outlined in WHO’s Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property, and in UNDP’s HIV and Health...
The 25th meeting of the WHO Expert Committee on the Selection and Use of Essential Medicines to revise and update the WHO Model List of Essential...
The 24th meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was held in Geneva, Switzerland, from 24 to 28 April 2023. The...